DPRXP5

Across TCGA pan-cancer cohorts, DPRXP5 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated DPRXP5 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher DPRXP5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated DPRXP5 expression acts as an unfavorable survival marker, although some lineages such as OV and LUAD show a favorable association.

BLCA, ESCA, and KIRC are the cancer types where DPRXP5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	III,IV	0.389	0.563	.011	63	view →
ESCA	DFS	Quartile	All	0.357	0.570	.005	42	view →
KIRC	OS	Quartile	II,III,IV	0.610	0.722	.016	20	view →
OV	OS	Tertile	IV	0.880	0.573	.030	18	view →
ACC	DFS	Tertile	II,III,IV	0.048	0.581	<.001	18	view →
PAAD	OS	Tertile	All	0.401	0.617	.009	9	view →
READ	DFS	Tertile	All	0.205	0.581	.039	9	view →
LUAD	DFS	Tertile	All	0.915	0.786	.017	6	view →
LUSC	OS	Tertile	II,III,IV	1.000	0.719	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

DPRXP5–BLCA (OS)

Open the BLCA breakdown →